CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- SC 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Results of operations · Other events
- S-3MEF Other S-3MEF
- 424B3 Offering Prospectus
- 4 Open-market buy Director bought 10,857 shares at $9.30 ($100,958)
- 4 Open-market sale General Counsel sold 8,497 shares at $10.50 ($89,219)
- 4 Open-market sale Chief Scientific Officer sold 172,585 shares at $9.33 ($1,610,097)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 22 · 423 filings